Guo, Jing
Yu, Siyi
Liu, Chunhong
Wang, Guiling
Li, Bin
Funding for this research was provided by:
National Natural Science Foundation of China (81774391, 81871507)
Article History
Received: 13 February 2019
Accepted: 23 October 2019
First Online: 9 December 2019
Ethics approval and consent to participate
: The study protocol was approved by the Medical Ethical Committee of the Beijing Hospital of Traditional Chinese Medicine on 12 March 2018 (permission number 2018BL-002-02). The trial was registered in the Chinese Clinical Trial Registry on 20 March 2018 (ChiCTR1800015282). Informed consent will be required for study participation. In addition, all researchers will be required to sign a pledge to protect the confidentiality of study participants. Any important protocol modifications (e.g., changes to eligibility criteria, outcomes, analyses) will be notified to the sponsor and funder first, and then the Principal Investigator will notify the centers and a copy of the revised protocol will be sent to the Principal Investigator to add to the Investigator Site File. Any deviations from the protocol will be fully documented using a breach report form. We will update the protocol in the clinical trial registry.
: Not applicable.
: The authors declare that they have no competing interests.